Home Diagnostics, On-Demand Care: Sterling Accuris launched “Accuris Express” in Ahmedabad, offering trained phlebotomists to collect eligible samples at home within 30 minutes via its app/website, aiming to cut the usual wait and hassle of lab visits. Diabetes Monitoring: In the CONNECT trial, continuous glucose monitoring (CGM) produced A1C drops in type 2 diabetes patients not using insulin, with results comparable to some strong non-insulin drug effects. Regulation & Access: India banned over-the-counter sales of all syrups (including cough/cold), effective June 16, shifting the Rs 57B market toward prescription-only dispensing and raising volume-consolidation concerns. Cardiac Innovation in India: Medtronic rolled out its PulseSelect pulsed field ablation system for atrial fibrillation, positioning it as a non-thermal option to expand treatment pathways. Public Health & Safety: Europe braces for another heatwave, with guidance focused on staying cool during peak hours and protecting vulnerable people from heat exhaustion and heatstroke. Clinical Governance: The UK Royal College of Physicians pushed back on DHSC plans to reform the GMC framework, warning about safeguards, oversight, and patient safety. Behavioral Health Infrastructure: Saudi Arabia’s SMC Healthcare subsidiary won a SAR 3.8B PPP contract to run a 150-bed behavioral care specialist hospital.